Trials / Completed
CompletedNCT01711424
An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,209 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational study of OPTIVE PLUS® in patients with dry eye disease in a routine clinical setting. Treatment decisions are made by the physician and reflect the physician's current standard of care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OPTIVE PLUS® | Patients with dry eye prescribed OPTIVE PLUS® in accordance with physician standard practice. |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2012-10-22
- Last updated
- 2014-03-17
- Results posted
- 2014-03-17
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01711424. Inclusion in this directory is not an endorsement.